Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Park Ridge, IL
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Baltimore, MD
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Cleveland, OH
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Philadelphia, PA
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Dallas, TX
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated:  5/3/2013
Clinical Research Facility
mi
from
Seattle, WA
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Status: Enrolling
Updated: 5/3/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated:  5/7/2013
Massachusetts General Hospital
mi
from
Boston, MA
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated: 5/7/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated:  5/7/2013
Massachusetts General Hospital
mi
from
Boston, MA
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated: 5/7/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Intravenous Thrombolysis for Wake-up Stroke
Safety of Intravenous Thrombolysis for Wake-up Stroke
Status: Enrolling
Updated:  5/7/2013
Swedish Medical Center
mi
from
Englewood, CO
Safety of Intravenous Thrombolysis for Wake-up Stroke
Safety of Intravenous Thrombolysis for Wake-up Stroke
Status: Enrolling
Updated: 5/7/2013
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Safety of Intravenous Thrombolysis for Wake-up Stroke
Safety of Intravenous Thrombolysis for Wake-up Stroke
Status: Enrolling
Updated:  5/7/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Safety of Intravenous Thrombolysis for Wake-up Stroke
Safety of Intravenous Thrombolysis for Wake-up Stroke
Status: Enrolling
Updated: 5/7/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety of Intravenous Thrombolysis for Wake-up Stroke
Safety of Intravenous Thrombolysis for Wake-up Stroke
Status: Enrolling
Updated:  5/7/2013
UT-Houston Health Science Center
mi
from
Houston, TX
Safety of Intravenous Thrombolysis for Wake-up Stroke
Safety of Intravenous Thrombolysis for Wake-up Stroke
Status: Enrolling
Updated: 5/7/2013
UT-Houston Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?
Can Acetaminophen PO Given 1-2 Hours Before Bilateral Myringotomy Tube (BMT) Placement Reduce Emergence Agitation (EA) in Children After General Sevoflurane Anesthesia?
Status: Enrolling
Updated:  5/8/2013
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?
Can Acetaminophen PO Given 1-2 Hours Before Bilateral Myringotomy Tube (BMT) Placement Reduce Emergence Agitation (EA) in Children After General Sevoflurane Anesthesia?
Status: Enrolling
Updated: 5/8/2013
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated:  5/13/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated: 5/13/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated:  5/13/2013
Kennedy Krieger Institute
mi
from
Baltimore, MD
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated: 5/13/2013
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated:  5/13/2013
University of Rochester
mi
from
Rochester, NY
Interventions for Communication in Autism Network
Multisite Randomized Control Treatment of Early Intervention for Spoken Communication in Autism
Status: Enrolling
Updated: 5/13/2013
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Maricopa Integrated Health System
mi
from
Phoenix, AZ
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Maricopa Integrated Health System
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Banner Good Samaritan Health Center
mi
from
Phoenix, AZ
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Banner Good Samaritan Health Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
University of Arizona
mi
from
Tucson, AZ
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Stanford Medical Center
mi
from
Stanford, CA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Stanford Medical Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
San Francisco General Hospital
mi
from
San Francisco, CA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Regional Medical Ctr.-San Jose
mi
from
San Jose, CA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Regional Medical Ctr.-San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Grady Memorial Hospital
mi
from
Atlanta, GA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
University of Kentucky Hospital
mi
from
Lexington, KY
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
University of Kentucky Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
University of Maryland Shock Trauma
mi
from
Baltimore, MD
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
University of Maryland Shock Trauma
mi
from
Baltimore, MD
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Johns Hopkins
mi
from
Baltimore, MD
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Detroit Receiving
mi
from
Detroit, MI
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Detroit Receiving
mi
from
Detroit, MI
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Henry Ford Hospital
mi
from
Detroit, MI
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Sinai-Grace Hospital
mi
from
Detroit, MI
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Sinai-Grace Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Hurley Medical Center
mi
from
Flint, MI
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Beaumont Health System
mi
from
Royal Oak, MI
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Beaumont Health System
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
North Memorial Hospital
mi
from
Robbinsdale, MN
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
North Memorial Hospital
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Regions Medical Center
mi
from
St. Paul, MN
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Regions Medical Center
mi
from
St. Paul, MN
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
NYP Columbia
mi
from
New York, NY
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
NYP Columbia
mi
from
New York, NY
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
University Hospital
mi
from
Cincinnatti, OH
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
University Hospital
mi
from
Cincinnatti, OH
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Oregon Health Sciences University
mi
from
Portland, OR
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Oregon Health Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
St. Luke's Hospital
mi
from
Bethlehem, PA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
St. Luke's Hospital
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Geisinger Medical Center
mi
from
Danville, PA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Jefferson Hospital
mi
from
Philadelphia, PA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Jefferson Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
University of Pennsylvania Hospital
mi
from
Philadelphia, PA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
University of Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Temple University
mi
from
Philadelphia, PA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Hahnemann University Hospital
mi
from
Philadelphia, PA
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Hahnemann University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Regional Medical Center/Elvis Presley Memorial Trauma Center
mi
from
Memphis, TN
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Regional Medical Center/Elvis Presley Memorial Trauma Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated:  5/14/2013
Brackenridge Hospital
mi
from
Austin, TX
Blood Tests to Study Injury Severity and Outcome in Traumatic Brain Injury Patients
Biomarkers of Injury and Outcome in ProTECT III
Status: Enrolling
Updated: 5/14/2013
Brackenridge Hospital
mi
from
Austin, TX
Click here to add this to my saved trials